Professor Michael (Monty) G Mythen

Prof Michael MythenTel: 020 3447 2810
Fax: 020 7679 4087

University College Hospital

Critical care, Anaesthesia and Perioperative Medicine, Theatres

Professional background

Monty is the Smiths Medical Professor of Anaesthesia and Critical Care at University College London. Director of The UCL Discovery Lab at The London 2012 Olympic legacy Institute of Sport Exercise and Health. Before returning to the UK, Monty was an assistant Professor at Duke University Medical Centre and acting Chief of Critical Care in the Department of Anesthesiology.

Monty is also an Elected Council Member of the Royal College of Anaesthetists and Leads their Perioperative Medicine Programme; Chair of The Board of the National Institute of Academic Anaesthesia; A Director of Xtreme-Everest; Co-Chairman of Evidence Based Peri-operative Medicine (EBPOM). Board member and Chair of the advisory board of the American Society of Enhanced Recovery (ASER). Monty was National Clinical Lead at the UK Department of Health for the Enhanced Recovery Partnership in the English NHS from May 09 - March 2013.

Contact details are:

Prof Michael (Monty) Mythen
Director of the Discovery Lab and Chair of the Scientific Advisory Board, ISEH
Smiths Medical Professor of Anaesthesia and Critical Care
UCL, Director
170 Tottenham Court Road, London W1T 7HA

Telephone: 020 3447 2838 – Administrator, Sarah Hayden [All travel/expense enquiries]

Research interests

  • Anaesthesia/critical care
  • Enhanced recovery from surgery
  • Surgical Outcomes Research Centre, UCLH


Five highly cited publications: (of >100 articles on Google Scholar; h-index 28)  
1. M. G. Mythen and A. R. Webb. Intraoperative Gut Mucosal Hypoperfusion Is Associated with Increased Postoperative Complications and Cost. Intensive Care Medicine 20 (2):99-104, 1994. (Cited  203 times). 
2. M. G. Mythen and A. R. Webb. Perioperative Plasma-Volume Expansion Reduces the Incidence of Gut Mucosal Hypoperfusion During Cardiac-Surgery. Archives of Surgery 130 (4):423-429, 1995. (Cited 333 times).     
3. E. BennettGuerrero, L. Ayuso, C. HamiltonDavies, W. D. White, G. R. Barclay, P. K. Smith, S. A. King, L. H. Muhlbaier, M. F. Newman, and M. G. Mythen. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277 (8):646-650, 1997. (Cited 92 times). 
4. T. J. Gan, E. Bennett-Guerrero, B. Phillips-Bute, H. Wakeling, D. M. Moskowitz, Y. Olufolabi, S. N. Konstadt, C. Bradford, P. S. A. Glass, S. J. Machin, and M. G. Mythen. Hextend (R), a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial. Anesthesia and Analgesia 88 (5):992-998, 1999. (Cited 133 times). 
5. N. J. Wilkes, R. Woolf, M. Mutch, S. V. Mallett, T. Peachey, R. Stephens, and M. G. Mythen. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesthesia and Analgesia 93 (4):811-816, 2001.(Cited 130 times).

GMC/GDC number: 2954675 

 Useful links